companydata.dkcompanydata.dk

ASCENDIS PHARMA A/S: Financial statements 2015

CVR: 29918791

Source: annual report 2015, Danish Business Authority

01/01/2015 – 31/12/2015

ASCENDIS PHARMA A/S (CVR 29918791) has filed annual accounts for 2015. In 2015, the company reported revenue of EUR 8,118,000 and a net result of EUR -32,922,000 compared with EUR -9,658,000 the year before. That is a decrease of 41.9% compared with the year before. The profit margin was -405.5%. Equity in the 2015 report amounted to EUR 120,329,000. The solvency ratio was 91.3%.

Revenue
EUR 8,118,000
Profit/Loss
EUR -32,922,000
Equity
EUR 120,329,000
Total Assets
EUR 131,774,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20158.1 mio. EUR--32.9 mio. EUR120.3 mio. EUR-
201414 mio. EUR--9.7 mio. EUR45.8 mio. EUR-
2012118.5 mio.63.7 mio.8.9 mio.134.6 mio.38

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is ASCENDIS PHARMA A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2015

Edwin William de Graaf leaves the board of ASCENDIS PHARMA A/SDec 7, 2015

As of December 7, 2015, Edwin William de Graaf has left the board of directors of ASCENDIS PHARMA A/S.

Thomas Paul Soloway steps down as økonomidirektør of ASCENDIS PHARMA A/SSep 25, 2015

As of September 25, 2015, Thomas Paul Soloway has stepped down as økonomidirektør of ASCENDIS PHARMA A/S.

Michael Gerhard Mayer leaves the board of ASCENDIS PHARMA A/SSep 3, 2015

As of September 3, 2015, Michael Gerhard Mayer has left the board of directors of ASCENDIS PHARMA A/S.

ASCENDIS PHARMA A/S: The 2014 annual report is outMay 8, 2015

ASCENDIS PHARMA A/S has published its annual report for 2014. Revenue came to DKK 13,983,000, and the net result was DKK -9,658,000.

About ASCENDIS PHARMA A/S

ASCENDIS PHARMA A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2006. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ASCENDIS PHARMA ApS and CADENZA PARTNERS ApS. The management consists of Jan Møller Mikkelsen, Anni Lotte Kirstine Pedersen and Michael Wolff Jensen. The board consists of Albert Cha (chair), Jan Møller Mikkelsen, Jean-Jacques Bienaime and Lars Holtug. The company is owned by Cede & Co. The company has 688 employees (2026). In 2025, the company reported revenue of EUR 720,132,000 and a net result of EUR -228,034,000 compared with EUR -378,084,000 the year before. Equity in the 2025 report amounted to EUR -162,821,000.

Source: annual report 2025, Danish Business Authority